Mimrylo is the first subcutaneous hepcidin mimetic approved to control hematocrit levels and reduce phlebotomy burden in patients with polycythemia vera.
The researchers found that the adjusted mean percentage change in body weight at the 24-month follow-up was −3.40% for the Mediterranean-style intervention and −3.51% for the control intervention. The ...
A healthy lifestyle in early childhood is associated with a reduced risk for inflammatory bowel disease (IBD), according to a study published online August 24 i ...
Effective atrial fibrillation management requires rate or rhythm control, anticoagulation based on risk scores, and lifestyle ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results